Christianne Roumie

January 23, 2024

VUMC establishes Realizing Accelerated Progress, Investigation, Implementation, and Dissemination in Learning Health Systems (RAPID-LHS) Center

The new center, supported by a $5 million grant from the Agency for Healthcare Research and Quality and the Patient-Centered Outcomes Research Institute will focus on training scientists and supporting research to minimize gaps between the generation of clinical evidence, implementation of proven interventions and development of informed public health policy.

By Jill Clendening
July 13, 2023

Grant renewal strengthens patient-centered outcomes research training program

The federal government has renewed its support of a learning healthcare system (LHS) T32 training program at Vanderbilt University Medical Center that prepares investigators to discover, evaluate and implement strategies for improving patient outcomes and, ultimately, the overall health of the community.

By Bill Snyder
July 13, 2023

Female health care workers more likely to leave profession during pandemic: HERO registry study

Vanderbilt research finds that female health care workers were more likely to leave or intend to leave the profession compared to male health care workers during the COVID-19 pandemic.

By Leigh MacMillan
May 8, 2023

Diabetes drugs associated with fewer adverse cardiac events in older veterans: study

Vanderbilt research finds that GLP1 receptor agonists — a class of diabetes medications — are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older veterans with no prior heart disease.

By Leigh MacMillan
September 10, 2020

Roumie to direct Master of Public Health program

Christianne Roumie, MD, MPH, has been named director of the Vanderbilt University School of Medicine Master of Public Health program, a two-year interdisciplinary program accredited by the Council on Education for Public Health.

By Jake Lowary
October 3, 2019

Diabetes drug study explores cardiovascular risks for patients with kidney disease

An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease.

By Paul Govern
August 2, 2018

Grant set to boost patient-centered outcomes research

Vanderbilt University Medical Center has been awarded a five-year federal grant to train investigators in Learning Healthcare Systems research, aimed at improving patient outcomes and the community’s overall health.
By Bill Snyder
August 31, 2017

Program for scientists to move discoveries into clinical practice

Vanderbilt University Medical Center (VUMC) has established a new career development program for scientists in implementation research. The goal is to speed the uptake and translation of scientific discoveries into routine clinical practice.
By Bill Snyder
June 12, 2014

Study tracks insulin’s risks as second-line diabetes medication

In an observational study by researchers at Vanderbilt University Medical Center, adults with type 2 diabetes who take insulin in addition to the recommended first-line drug therapy, metformin, had a 30 percent higher risk of heart attack, stroke or death when compared to similar patients who instead augment their metformin regimen with a sulfonylurea.
By Paul Govern
November 8, 2012

Commonly prescribed oral diabetes drug offers cardiac benefits

Patients prescribed the diabetes drug metformin have a lower risk for heart attack, stroke and death than patients taking sulfonylurea drugs.
By VUMC News and Communications